Skip to content
Insider tapeFilings through Fri, Oct 9
Watchlist
SHC

Sotera Health (SHC) stock: insider trades, news & valuation

Heavy selling
Close · Oct 9, 2026 $18.06 +1.3% on the day +14.4% over 12 months 52-week range $13.13 – $19.57

Share price and insider trades

SHC closeInsider buyInsider sale
1214161820NovDecJan 2026FebMarAprMayJunJulAugSepOctSold $2,826,000 on 2026-08-07 · Michael P RutzSold $12,337,500 on 2025-12-08 · Michael B. Petras Jr.Sold $21,173,528 on 2026-08-17 · Michael B. Petras Jr.Sold $423,273,600 on 2025-12-03 · Gtcr Fund Xi/A Lp, Warburg Pincus Llc, Warburg Pincus Partners Gp LlcSold $610,800,000 on 2026-03-06 · Gtcr Co-Invest Xi Lp, Warburg Pincus Partners Gp Llc, Warburg Pincus Partners Ii, L.P.Sold $751,200,000 on 2025-11-10 · Gtcr Fund Xi/A Lp, Pincus Private Equity Xi-c, L.p. Warburg, Warburg Pincus Partners Ii, L.P.Sold $772,778,080 on 2026-05-13 · Gtcr Fund Xi/C Lp, Pincus (cayman) Xi, L.p. Warburg, Pincus Xi, L.p. Warburg
Bought, 12 months$0
Sold, 12 months$2.59B
Insiders buying0
Insiders selling11

Sotera Health insider trading at a glance (Oct 9, 2026): in the past 12 months, 0 insiders bought $0 and 11 sold $2.59B of SHC stock on the open market.

SHC insider buying and selling by quarter

Open-market purchases (green, above the line) and sales (red, below), by trade date.

Q4 2025: $1.19B sold (9 trades)Q4 2025Q1 2026: $611M sold (3 trades)Q1 2026Q2 2026: $773M sold (3 trades)Q2 2026Q3 2026: $24.0M sold (3 trades)Q3 2026Q4 2026
QuarterBoughtPurchasesSoldSales
Q4 2026—0—0
Q3 2026—0$24.0M3
Q2 2026—0$773M3
Q1 2026—0$611M3
Q4 2025—0$1.19B9

Valuation, profit and volume

P/E (trailing)n/aSector median —
Market value— 
Profit margin—Revenue growth —
Volume vs. 50-day0.8×Last 5 sessions
Insiders' paper profit—On all tracked purchases —

Summary

Over the past 12 months, 0 Sotera Health Co insiders reported open-market purchases totaling $0, while 11 insiders reported sales totaling $2.59B. 0 of 18 recorded sales were made under pre-scheduled Rule 10b5-1 trading plans, which are usually less informative than discretionary sales.

Insider transactions

Open-market purchases and sales.

Filed Insider Type Shares Price Value Since Score
Aug 19SEC Michael B. Petras Jr.Chair Sell 850,0003,969,393 held (−18%) $18.50 $15.7M -2.4% —
Aug 19SEC Michael B. Petras Jr.Chair Sell 294,515397,912 held (−43%) $18.50 $5.4M -2.4% —
Aug 11SEC Michael P RutzPresident Sell 150,000334,279 held (−31%) $18.84 $2.8M -4.1% —
May 15SEC Pincus (cayman) Xi, L.p. WarburgDirector Sell 19,102,952 $15.17 $290M +19.1% —
May 15SEC Pincus Xi, L.p. WarburgDirector Sell 19,102,952 $15.17 $290M +19.1% —
May 15SEC Gtcr Fund Xi/C LpDirector Sell 12,735,301 $15.17 $193M +19.1% —
Mar 10SEC Warburg Pincus Partners Ii, L.P.Director Sell 15,000,00019,102,952 held (−44%) $15.27 $229M +18.3% —
Mar 10SEC Warburg Pincus Partners Gp LlcDirector Sell 15,000,00019,102,952 held (−44%) $15.27 $229M +18.3% —
Mar 10SEC Gtcr Co-Invest Xi LpDirector Sell 10,000,00012,735,301 held (−44%) $15.27 $153M +18.3% —
Dec 10SEC Michael B. Petras Jr.CEO, Chair Sell 394,8614,819,393 held (−8%) $16.45 $6.5M +9.8% —
Dec 10SEC Michael B. Petras Jr.CEO, Chair Sell 315,896552,790 held (−36%) $16.45 $5.2M +9.8% —
Dec 10SEC Michael B. Petras Jr.CEO, Chair Sell 39,243 $16.45 $646K +9.8% —
Dec 5SEC Warburg Pincus Partners Gp LlcDirector Sell 9,720,00034,102,952 held (−22%) $16.33 $159M +10.6% —
Dec 5SEC Warburg Pincus LlcDirector Sell 9,720,00034,102,952 held (−22%) $16.33 $159M +10.6% —
Dec 5SEC Gtcr Fund Xi/A LpDirector Sell 6,480,00022,735,301 held (−22%) $16.33 $106M +10.6% —
Nov 12SEC Warburg Pincus Partners Ii, L.P.Director Sell 18,000,00043,822,952 held (−29%) $15.65 $282M +15.4% —
Nov 12SEC Pincus Private Equity Xi-c, L.p. WarburgDirector Sell 18,000,00043,822,952 held (−29%) $15.65 $282M +15.4% —
Nov 12SEC Gtcr Fund Xi/A LpDirector Sell 12,000,00029,215,301 held (−29%) $15.65 $188M +15.4% —

Insiders at Sotera Health Co

InsiderBoughtSoldLast filingScore
Warburg Pincus Partners Ii, L.P.Director — $511M Mar 10, 2026 —
Warburg Pincus Partners Gp LlcDirector — $388M Mar 10, 2026 —
Gtcr Fund Xi/A LpDirector — $294M Dec 5, 2025 —
Pincus (cayman) Xi, L.p. WarburgDirector — $290M May 15, 2026 —
Pincus Xi, L.p. WarburgDirector — $290M May 15, 2026 —
Pincus Private Equity Xi-c, L.p. WarburgDirector — $282M Nov 12, 2025 —
Gtcr Fund Xi/C LpDirector — $193M May 15, 2026 —
Warburg Pincus LlcDirector — $159M Dec 5, 2025 —
Gtcr Co-Invest Xi LpDirector — $153M Mar 10, 2026 —
Michael B. Petras Jr.Chair — $33.5M Aug 19, 2026 —
Michael P RutzPresident — $2.8M Aug 11, 2026 —

SHC stock: common questions

Are Sotera Health Co insiders buying SHC stock?

In the past 12 months, 0 insiders reported open-market purchases of SHC worth $0.

Are Sotera Health Co insiders selling SHC stock?

11 insiders reported sales worth $2.59B over the same period.

Where does this data come from?

Every transaction comes from Form 4 filings that insiders must submit to the SEC within two business days of a trade. We pull them from SEC EDGAR every night.

What is SHC's 52-week range?

Over the past year SHC has traded between $13.13 and $19.57. It last closed at $18.06 on Oct 9, 2026.